Shih C S, Wang L S, Yang S S, Fahn H J, Wu L H, Chen W Y, Huang M H
Department of Surgery, Veterans General Hospital-Taipei, Medical College of National Yang-Ming University, Taiwan.
Scand J Thorac Cardiovasc Surg. 1996;30(3-4):157-61. doi: 10.3109/14017439609107261.
DNA flow cytometric analysis was performed for prediction of malignancy potential, and hence of outcome, in 17 patients aged 29-76 (mean 52) years with cartilaginous tumour of the chest wall. Histologically there were nine chondromas and eight chondrosarcomas. The chondrosarcomas (3 grade I, 4 grade II, 1 grade III) were significantly larger than the chondromas (13.6 +/- 7.8 vs 4.2 +/- 2.0 cm, p < 0.001). DNA flow cytometry was performed on paraffin-embedded blocks of resected tumour. In eight of the 17 tumours (6 chondromas, 1 grade I and 1 grade II chondrosarcoma) measurement of DNA content failed because of low cellularity and severe calcification. Aneuploid DNA content was detected only in three chondrosarcomas (2 grade II, 1 grade III). The synthetic phase fraction was less than 15% in all the studied chondromas, but exceeded 25% in four of six chondrosarcomas. This case series though small, may indicate a trend towards association between higher histologic grading and greater incidence of aneuploidy with higher synthetic phase fraction. Tumour size, histologic grade, DNA ploidy and adequacy of surgical resection are the main influences on prognosis.
对17例年龄在29 - 76岁(平均52岁)的胸壁软骨肿瘤患者进行了DNA流式细胞术分析,以预测恶性潜能及预后。组织学检查有9例软骨瘤和8例软骨肉瘤。软骨肉瘤(3例I级,4例II级,1例III级)明显大于软骨瘤(13.6±7.8 vs 4.2±2.0 cm,p < 0.001)。对切除肿瘤的石蜡包埋块进行DNA流式细胞术检测。17个肿瘤中有8个(6个软骨瘤,1个I级和1个II级软骨肉瘤)因细胞数量少和严重钙化而未能进行DNA含量测定。仅在3个软骨肉瘤(2个II级,1个III级)中检测到非整倍体DNA含量。所有研究的软骨瘤的合成期分数均小于15%,但6个软骨肉瘤中有4个超过25%。尽管该病例系列较小,但可能表明组织学分级越高与非整倍体发生率越高以及合成期分数越高之间存在关联趋势。肿瘤大小、组织学分级、DNA倍体和手术切除的充分性是影响预后的主要因素。